< 1 minute read
Sep. 18, 2021
Compound 34: A Mechanism-Based Inhibitor of Lysine-Specific Demethylase LSD1
“compound 34”
mech.-based inh. of monoamine oxidase LSD1 orally efficacious in xenograft model from optimization of known starting point ACS Med. Chem. Lett., May 12, 2020 Constellation Pharma., Cambridge, MA
Loading...
